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Abstract The hexachlorophene (HCP) is a highly lipophilic chlorinated bisphenol present in hygienic and dermatological
products. The HCP accumulates preferentially in adipose tissue that is a privileged source of mesenchymal stem cells
(MSCs). The evaluation of the potential effects of HCP on MSCs is important for their medical application. Here we
examined the effects of HCP on murine adipose tissue-derived stem cells (ADSCs) and human umbilical cord-derived stem
cells (UCSCs) in cell culture. We found that 10-4 and 10-5 M HCP inhibits proliferation, osteogenesis and increases
apoptosis of ADSCs and UCSCs. While the effect of HCP on proliferation and differentiation potential of these two cell
lines was similar, the UCSCs appeared much more resistant to HCP-induced apoptosis than ADSCs. These results suggest
that the adipose tissue-derived ADSCs have higher sensitive for HCP than umbilical cord-derived UCSCs and indicate that
the umbilical cord can be a preferable source of MSCs for prospective medical applications in the future.
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1 Introduction
The ability of pluripotent stem cells to differentiate into
osteoblasts, chondrocytes, myoblasts, adipocytes and neu-
rons makes them irreplaceable tool in regenerative medi-
cine [1, 2]. The stem cells isolated from adult human tissue
contain a high percentage of Mesenchymal Stem Cells
(MSCs). Studies performed in recent years showed that the
adipose (fat) tissue might be a preferred source of MSCs
due to its availability and ease of acquisition. However, the
adipose tissue has affinity for and accumulates highly
lipophilic chemicals, such as insecticides, polychlorinated
biphenyls, hexachlorophene, polycyclic aromatic hydro-
carbons, which are present in food (especially produced in
industrialized farms) and personal hygiene products [3].
These chemicals constitute a potential human health risk; a
sudden loss of fat tissue after intense exercise or extreme
weight loss causes rapid release of adipose tissue-accu-
mulated chemicals into the blood, liver, kidneys and brain.
In addition, these chemicals may affect proliferation and/or
differentiation of adipose tissue-derived MSCs.
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Hexachlorophene [2,2’-methylenebis-(3,4,6-
trichlorophenol)] (HCP) is a chlorinated bisphenol with
strong bacteriostatic properties against many Gram-posi-
tive bacteria (including Staphylococcus) [4] that is used in
soaps, creams and dermatological preparations. Because
HCP is very resistant to biotransformation it accumulates
in the environment and bioaccumulates in food chain [5].
Animal studies have shown a clear chronic negative effect
of HPC on human health. HCP administered orally or
vaginally in high doses was embryotoxic and teratogenic in
rats [6]. Lokanatha et al. [7] showed that HCP had, through
the inhibition of succinate dehydrogenase, neurotoxic
effects on rat brain. The poisoning symptoms of HCP are
neurologic, cardiovascular, respiratory, gastrointenstinal
and dermatological. The range of lethal dose in adult
human is 2–10 g per kg of body mass [8]. However, the
minimal lethal dose is unknown. Because of its high
hydrophobicity the HCP rapidly accumulates in adipose
tissues and central nervous system (CNS). Within the
nervous system the myelin has a significant affinity for
HCP. Experimental studies showed inhibitory effect of
HCP on synthesis of myelin possibly by inhibition of
oxidative phosphorylation [5]. HCP is metabolized in the
liver by glucuronidation and is excreted into bile.
Here we investigated the effect of various concentra-
tions of HCP on the proliferatation, apoptosis and differ-
entiation into osteaoblasts of MSCs from two different
sources: adipose tissue and umbilical cord. We also tested
whether preincubation of MSCs with HCP affects their
differentiation into osteoblasts.
2 Materials and methods
2.1 Animals and human tissues samples
Fat tissue was isolated form 8 weeks C57BL/6 mice. Mice
were sacrificed by anesthetic overdose (pentobarbital,
400 mg/kg; Polypharm S.A., Warsaw, Poland). Fat tissue
was isolated from gonadal and kidney localization under
aseptic conditions (laminar flow cabinet) and transferred to
falcon probe which contained 10 ml PBS with antibiotics
penicillin–streptomycin (500 IU/ml, Thermo Fisher Sci-
entific, Poland) until use.
Human umbilical cord samples were downloaded post-
partum. After isolation umbilical cord samples were
transferred to falcon probe which contained 30 ml PBS
with antibiotics (penicillin–streptomycin (500 IU/ml,
Thermo Fisher Scientific, Poland) until use.
2.2 Cell isolation and culture
Experiments were performed on two primary cells lines:
adipose derived stem cells (ADSCs)—mesenchymal stem
cells isolated from adipose tissue of C57BL/6 mice, and
umbilical cord stem cells (UCSCs)—mesenchymal stem
cells isolated from human umbilical cord.
ADSCs were isolated by the method described by
Gronthos et al. [9] with our own modification. The adipose
tissue was digested in type 1 collagenase (1 mg/ml; Sigma
Aldrich, Poland) for 1 h at 37 C with shaking in water
bath. Digested tissue was strained through 40 lm strainer,
washed with culture medium (DMEM F12, 10% FBS,
penicillin/streptomycin, Thermo Fisher Scientific, Poland)
and centrifuged for 5 min at 5009g. The cells recovered in
pellets were counted and seeded onto 6 well dishes at
1.5 9 106 cells/well and cultured at 37 C in 5% CO2. The
cell culture medium was changed after 24 h. Cells were
grown to 90% confluency, washed with PBS, harvested by
trypsinization (0.25% trypsin in PBS) and seeded into
75 cm2 culture bottles at 106 cells/bottle. Cells were cul-
tured up to 18 passage. The proliferation time between
passages equals 96 h.
Human UCSCs were isolated from umbilical cord
Wharton’s jelly by the method described by Ishige et al.
[10] with our own modification. Fragments of umbilical
cord were cut into small pieces and cultured at 37 C in 5%
CO2 in DMEM medium containing 4.5 g/l of glucose
(Thermo Fisher Scientific, Poland), 20% FBS (Thermo
Fisher Scientific, Poland) and penicillin/streptomycin
(Thermo Fisher Scientific, Poland). The culture medium
was replaced once a week to achieve 90% cell confluency.
Cells were rinsed twice with PBS (Thermo Fisher Scien-
tific, Poland), trypsinized (0.25% trypsin in PBS, Thermo
Fisher Scientific, Poland) and seeded in 25 cm2 cell culture
flasks at 3 9 105 cells/flask. Cells were cultured up to 24
passage. The proliferation time between passages equals
72 h.
After 2nd and 3rd passage, ADSCs and UCSCs cells
were frozen in culture medium with 10% DMSO (Sigma
Aldrich, Poland) and stored under liquid nitrogen.
Mesenchymal stem cells isolated from mouse adipose
tissue and human umbilical cord were derived from tissue
lipophilic compounds free.
2.3 Flow cytometry analysis
The ADSCs and UCSCs were collected using Acutase (BD
Biosciences, Poland) and washed in PBS (Sigma Aldrich,
Poland). The presence of surface markers: CD29?,
CD105?, CD106? and CD45- (Becton–Dickinson,
Poland) was determined in 2nd and 3rd passage cells using
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flow cytometer FACS Calibur and the results were ana-
lyzed by Cell Quest pro software (both from BD, USA).
2.4 Hexachlorophene preparation
HCP was purchased from Sigma Aldrich, Poland. HCP was
dissolved in 10-1 M DMSO (Sigma Aldrich, Poland),
aliquoted and stored in glass bottles in the dark at 4 C. We
have used 10-7–10-4 M HCP concentration in the culture
medium. The DMSO content in the samples was 0.01%.
2.5 Proliferation assays
2.5.1 Cell culture
ADSCs or UCSCs in a log phase stage of growth were
harvested by trypsinization (0.05% solution, Thermo Fisher
Scientific, Poland) and pelleting at 3009g for 5 min. Cell
pellets were resuspended in culture medium and 1.5 9 104
cells/ml were seeded into 96-well plate (200 ll per well).
After 24 h cells were washed twice with PBS, and 10-7–
10-4 M HCP was added in fresh culture medium. Control
cells were grown in culture medium without HCP and with
0.01% DMSO. The proliferation assay will be evaluated
using three independent cell number comparison tests
which were performed as previously described [11].
2.5.2 MTT assay
24, 48 and 72 h after HCP addition the culture medium was
discarded and fresh culture medium containing MTT
(1 mg/ml, Sigma Aldrich, Poland) was added directly to
the wells. After 2 h incubation (37 C, 5% CO2,) the
medium was discarded, cells were rinsed 3 times with PBS
and to dissolve the formazan crystals the 100 ll of DMSO
was added to the wells. The absorbance was measured at
570 nm using FLUOstar Omega reader (BMG Labtech,
Sweden).
2.5.3 Neutral Red assay
24, 48 and 72 h after HCP addition the culture medium was
discarded and fresh culture medium containing Neutral
Red (25 mg/ml; Sigma Aldrich, Poland) was added directly
to the wells. After 2 h of incubation (37 C, 5% CO2,) the
medium was discarded and cells were rinsed 3 times with
PBS. Subsequently, in order to dissolve the pigment, cells
were rinsed with 100 ll of 1% acetic acid, 50% ethanol,
49% water solution (Sigma Aldrich). The absorbance was
measured at 570 nm using FLUOstar Omega reader (BMG
Labtech, Sweden).
2.5.4 Sulforodamine B assay
24, 48 and 72 h after HCP addition the culture medium was
discarded and cells were fixed with 50% trichloroacetic
acid (Sigma Aldrich, Poland,; 100 ll per well, 1 h, 4 C).
Fixed cells were washed 3 times in water, air dried and
100 ll of sulforodamine B (0.4% in 1% acetic acid; Sigma
Aldrich, Poland) was added. After 30 min incubation cells
were washed with 1% acetic acid 4 times, air dried and
10 mM Trismabase (100 ll/well; Sigma Aldrich, Poland)
was added to dissolve the pigment. The fluorescence was
measured at excitation 570 nm (± 10) and emission
590 nm (± 10) using FLUOstar Omega reader (BMG
Labtech, Sweden).
2.6 Apoptosis assay
ADSCs or UCSCs in a log phase growth were harvested
and seeded at 3 9 104 cells/well and 5x104 cells/well,
respectively, in 24-well plate (1 ml/well). 24 h later cells
were incubated with 10-7–10-4 M HCP. Control cells were
grown in culture medium without HCP and with 0.01%
DMSO. After 24 and 72 h incubation cells were washed
twice with PBS and pelleted (5009g, 5 min). Cell pellets
were washed twice with PBS, centrifuged and resuspended
in annexin binding buffer with addition of 4.5 ll annexin
V-FITC antibody (eBioscence, Poland) and 8 ll propidium
iodide 1 mg/ml (Sigma Aldrich, Poland). After 20 min
incubation cells were washed with PBS and analyzed by
flow cytometry (FACS Calibur, BD, USA). Evaluation of
live, apoptotic and necrotic cells was performed using Cell
Quest software.
2.7 Osteogenesis of ADSCs and UCSCs
2.7.1 ADSCs and UCSCs osteogenesis in the presence
of HCP in osteogenic induction medium
ADSCs or UCSCs in a log phase were plated in 24-well
plate at 4 9 104 cells/well (ADSCs) and 2 9 104 cells/well
(UCSCs). Cells were grown to 95% confluency and
osteogenic induction medium (DMEM 4.5 g/l D-Glucose or
DMEM F12, 10% FBS, 200 lM L—ascorbic acid
2-phosphate, 100 nM dexamethasone, 10 mM b-Glyc-
erophosphate—all from Sigma Aldrich, Poland) was added
directly to the wells. The composition of the osteogenic
induction medium was described by Kim et al. [12] and
Wang et al. [13] and the concentration of the individual
compounds were selected experimentally by us. The HCP
was added at 10-7–10-4 M. The control cells were cultured
in osteogenic induction medium without HCP and with
0.01% DMSO (positive control) or culture medium without
osteogenic supplement, HCP and with 0.01% DMSO
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(negative control). Cells were cultured for 3 weeks and
medium was changed every 3–4 days.
2.7.2 ADSCs and UCSCs preincubation with HCP
followed by osteogenesis without HCP in osteogenic
induction medium
Mesenchymal Stem Cells in a log phase stage of growth
were plated in 25 cm2 flasks at density 4 9 105 cells/flask
(ADSCs) and 2 9 105 cells/flask (UCSCs). 24 h later cells
were treated with different concentrations (10-7–10-4 M)
of HCP. Cells were grown to 90-95% confluence, harvested
by trypsinization and seeded in 24-well plate at 4 9 104
cells/well (ADSCs) and 2 9 104 cells/well (UCSCs). After
cells had formed monoleyer they were cultured for 3 weeks
in osteogenic induction medium without HCP. Medium
was changed every 3–4 days. The positive control cells
were cultured in osteogenic induction medium without
HCP and with 0.01% DMSO. The negative control cells
were cultured in medium without osteogenic supplements
and with 0.01% DMSO.
2.7.3 Alizarin red staining
After 3 weeks of osteogenic differentiation cells were fixed
in 4% paraformaldehyde (Sigma Aldrich, Poland) for
20 min. Fixed cells were washed with PBS and stained
with Alizarin Red S (2 g/100 ml of distilled water; Sigma
Aldrich, Poland) pH 4.1–4.3 for 20 min.
Alizarin Red S stains red the calcium deposits formed in
the differentiated cells (osteoblasts) The results are pre-
sented using a five-point visual scale: undifferentiated cells
(-), differentiated cells depending on the intensity of
staining (?), (??), (???), (????).
2.8 Statistical analysis
Statistical analysis was performed using unpaired t-tests
and one-or two-way analysis of the variance, followed by
the Tukey test or Bonferroni correction (in the case of a
normal distribution) or non-parametric Kruskal–Wallis and
Mann–Whitney U tests (in the case of abnormal distribu-
tion). Assessment of the distribution of data was evaluated
using the Shapiro–Wilk test. GraphPad Prism software was
used (ver. 5; GraphPad Software, Inc., La Jolla, CA, USA).
p\ 0.05 was a statistically significant difference.
3 Results
3.1 Mesenchymal cells phenotype
Mice adipose-derived stem cells (ADSCs), after third
passage of in vitro culture, expressed CD29, CD105 and
CD106 surface markers. Over 95% of cells expressed
CD29, CD105 and CD106 markers. The highest expression
was found for CD29 marker. There was a weak expression
of CD105 and CD106 and the CD45 positive cells were
absent. The results are presented in Fig. 1.
Human UCSCs also expressed CD29, CD105 and
CD106 stem cell surface markers Over 95% of cells
expressed CD29, CD105 and CD106 markers. The CD45
positive cells were absent. The highest level of expression
was observed for CD29[CD105[CD106. The UCSCs
also expressed CD73, CD90 surface markers (data not
shown) and were negative for CD34 expression (data not
shown). The results are presented in Fig. 2.
3.2 Proliferation assays
3.2.1 ADSCs
The results of MTT, NR and SRB, three independent cell
number comparison tests, showed that there was no sig-
nificant change in proliferation of ADSCs after 24–72 h
treatment with 10-7 and 10-6 M HCP in comparison to the
control. The higher concentration of HCP (10-5 and 10-4
M) significantly decreased (75% of the control value, p\
0.0001) cell proliferation after 72 h. Toxic effect of the
highest concentration (10-4 M) of HCP was already visible
after 24 h of treatment. Figure 3 shows the results (pre-
sented as a mean ± SEM) from 3 independent
experiments.
3.2.2 UCSCs
The results of MTT, NR and SRB proliferation assays
showed that there was no significant change in proliferation
of UCSCs after 24-72 h treatment with 10-7 and 10-6 M
HCP in comparison to the control. There was slight, but
statistically significant increase of proliferation after 48 h
treatment with 10-6 M HCP (p\ 0.05) and 72 h treatment
with 10-7 M HCP (p\ 0.05) when compared to the con-
trol. The highest concentration of HCP (10-4 M) caused
significant reduction of cell proliferation, especially after
72 h treatment (Fig. 4). The results from 3 independent
experiments are shown as a mean ± SEM.
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Fig. 1 Stem cell surface markers expressed by ADSCs A CD 105, CD 29, B CD 106 and C CD 45
Fig. 2 Stem cells surface markers expressed by UCSCs A CD 105, CD 29, B CD 106 and C CD 45
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3.3 Apoptosis assay
3.3.1 ADSCs
The treatment (24 and 72 h) with HCP (10-7 and 10-6 M)
did not affect the number of necrotic or apoptotic ADSC
cells when compared to the control (Fig. 5A, B). However,
there was statistically significant dose-dependent decrease
in the percentage of live cells after treatment with 10-5 and
10-4 M HCP. HCP in concentration 10-5 and 10-4 M
caused significant increase in necrosis and especially in
apoptosis. The highest number of necrotic and apoptotic
cells were found in 10-4 M HCP after 72 h treatment
Fig. 3 Effect of HCP treatment on ADSCs proliferation assessed by MTT assay A 24 h, B 48 h, C 72 h; NR assay D 24 h, E 48 h, F 72 h and
SRB assay, G 24 h, H 48 h, I 72 h (mean ± SEM)
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(p\ 0.0001) (Fig. 5B). The results from 3 independent
experiments are shown as a mean.
3.3.2 UCSCs
Similar to the results obtained for ADSCs, the 10-7 and
10-6 M HCP did not affect the percentage of live UCSCs
when compared to the control group (Fig. 6A, B). How-
ever, the UCSCs were less susceptible to HCP treatment
than ADSCs. After 24 h HPC treatment in concentration
form 10-7 to 10-4 M there was no significant change in the
percentage of viable cells or in the percentage of necrotic
or apoptotic cells. After 72 h HCP treatment in
concentration of 10-5 and 10-4 M there was statistically
significant dose depended decrease in the percentage of
viable cells (about 17%, p\ 0.0001, and about 28%
p\ 0.001, respectively). In concentration of 10-5 M HCP
the cells mainly died by apoptosis and there was no sig-
nificant increase in necrosis. The highest concentration of
HCP (10-4 M) caused increase in both necrosis (about
930%, p\ 0.001) and apoptosis (about 630%, p\ 0.001)
(Fig. 6B). The results from 3 independent experiments are
shown as mean values.
Fig. 4 Effect of HCP treatment on UCSCs proliferation assessed by MTT assay A 24 h, B 48 h, C 72 h; NR assay D 24 h, E 48 h, F 72 h and
SRB assay, G 24 h, H 48 h, I 72 h (mean ± SEM)
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3.4 Osteogenesis of ADSCs and UCSCs
3.4.1 ADSCs and UCSCs osteogenesis in the presence
of HCP in osteogenic induction medium
The 10-4 M HCP added to the osteogenic induction
medium caused death of both ADSCs and UCSCs cells
before the end of experiment (not shown). The addition of
10-5 M HCP significantly inhibited osteogenesis of
ADSCs and UCSCs (there was no visible calcium deposits
after Alizarin Red staining Figs. 7C, 8C). Similar effect
was observed for negative control (Figs. 7B, 8B). Treat-
ment with lower concentration (10-6 and 10-7 M) of HCP
resulted in lower differentiation level (Figs. 7D–E, 8D–E)
when compared to the control (Figs. 7A, 8A). Results of
microscopic evaluation of the intensity of Alizarin Red
staining are shown in Table 1.
3.4.2 ADSCs and UCSCs preincubation with HCP
followed by osteogenesis without HCP in osteogenic
induction medium
ADSCs and UCSC cells preincubated with 10-4 M HCP
remained undifferentiated (Figs. 9C, 10C) similar to
negative control (Figs. 9B, 10B). The preincubation with
HCP in lower concentration (10-5–10-7 M) did not inhibit
osteogenesis (Figs. 9D–F, 10D–F) but the level of differ-
entiation was lower than in positive control (Figs. 9A,
10A). Results of the microscopic evaluation of the intensity
of Alizarin Red staining are shown in Table 2.
4 Discussion
The ability of ADSCs to differentiate into different types of
cells is widely used in tissue engineering and regenerative
medicine. Several studies described the use ADSC in tissue
remodeling, stimulation of peripheral nerve repair [14],
functional recovery in spinal cord damage [15], diabetes
treatments [16] and liver injury repair [17]. The ADSCs are
also used as filler in plastic and cosmetic surgery [18] and
as the autologous chondrocytes alternative for a repair of
articular cartilage in the knee [19]. The ADSCs were also
used, in combination with fibrin glue and a biodegradable
scaffold, to repair the calvarial bone defects [20]. For all
these applications the ADSCs should be isolated from
healthy and young donors.
Fig. 5 A, B Effect of HCP on ADSCs apoptosis and necrosis after 24 and 72 h treatment
Fig. 6 A, B Effect of HCP on UCSCs apoptosis and necrosis after A 24 and B 72 h treatment
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Recently, Alt et al. [21] demonstrated that the number of
tissue resident ADSCs decrease significantly with the
increasing donor age. The ADSCs isolated from old donors
display senescent features compared with cells isolated
from young donors. Li et al. [22] reported that the donor’s
age has the impact on proliferation of human bone marrow
MSCs. Similarly, Paxson et al. [23] showed the lower
number of colony forming units, lower growth potential
and telomerase activity in lung-derived MSCs from older
mice. Choudhery et al. [24] reported the effect of donor age
on expansion and differentiation potential of human
ADSCs and showed that the ADSCs from older donors had
Fig. 7 Alizarin Red staining on 21th day of ADSCs osteogenesis
(calcium deposits formed in the differentiated cells (osteoblasts) are
orange/red color). A Positive control (differentiated cells without
HCP). B Negative control (cells cultured in culture medium without
osteogenesis factors). C HCP 10-5 M, D HCP 10-6 M, E HCP 10-7
M. Images acquired by inverted light microscope (ZEISS AX10,
Poland; magnification 9100)
Fig. 8 Alizarin Red staining on 21th day of UCSCs’ osteogenesis
(calcium deposits formed in the differentiated cells (osteoblasts) are
orange/red color). A Positive control (differentiated cells without
HCP). B Negative control (cells cultured in culture medium without
ostegenesis factors). C HCP 10-5 M, D HCP 10-6 M, E HCP 10-7
M. Images acquired by inverted light microscope (ZEISS AX10,
Poland; magnification 9100)
Table 1 ADSCs and UCSCs
Alizarin Red staining intensity
(microscopic evaluation)
Stem
cells
Control positive Control negative HCP
10-5 M 10-6 M 10-7 M
ADSCs ???? – – ?? ??
UCSCs ???? – – ?? ??
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reduced viability, proliferation and differentiation poten-
tial. In contrast, Legzdina et al. [25] did not found age-
related decrease in potential of growth and differentiation
of ADSCs isolated from human donors. Authors concluded
that the differences between studies from different labo-
ratories resulted from donor-specificity and the intricacy in
the dynamics of cell subsets present in ADSC population.
In addition it has been shown that various diseases may
Fig. 9 Alizarin Red staining on 21th day of ADSCs osteogenesis
(calcium deposits formed in the differentiated cells (osteoblasts) are
red–orange/red color). A Positive control (differentiated cells without
preincubation with HCP in osteogenic induction medium). B Negative
control (cells cultured in culture medium without preincubation with
HCP). C–E Differentiated cells preincubated with HCP before the
beginning of the differentiation process. C 10-4 M HCP. D 10-5 M
HCP. E 10-6 M HCP. F 10-7 M HCP. Images acquired by inverted
light microscope (ZEISS AX10, Poland; magnification 9100)
Fig. 10 Alizarin Red staining on 21th day of UCSCs osteogenesis
(calcium deposits formed in the differentiated cells (osteoblasts) are
orange/red color). A Positive control (differentiated cells without
preincubation with HCP in osteogenic induction medium). B Negative
control (cells cultured in culture medium without preincubation with
HCP). C–E Differentiated cells preincubated with HCP before the
beginning of the differentiation process. C 10-4 M HCP. D 10-5 M
HCP. E 10-6 M HCP. F 10-7 M HCP. Images acquired by inverted
light microscope (ZEISS AX10, Poland; magnification 9100)
Table 2 ADSCs and UCSCs
Alizarin Red staining intensity
(microscopic evaluation)
Stem
cells
Control positive Control negative HCP
10-4 M 10-5 M 10-6 M 10-7 M
ADSCs ???? – – ?? ?? ???
UCSCs ???? – – ?? ?? ???
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affect number, proliferation and differentiation properties
of MSCs [26].
In presented here study we evaluated how exposure to
lipophilic substance HCP affects quality of MSCs (ADSCs
and UCSCs). We found three major effects of HCP on
MSCs cultured in vitro: (1) high toxicity (cell growth
arrest) in the highest doses, (2) increased apoptosis espe-
cially pronounced in UCSCs, (3) inhibition of differentia-
tion into osteoblasts, which persisted after HCP had been
removed before induction of differentiation. The latter is of
particular interest because it suggests that HCP causes
long-lasting, or even permanent, changes in cell home-
ostasis, which inhibits the differentiation process. Similar
long-lasting effects of the milieu on MSCs’ quality had
been reported by others. Kim et al. [27] compared UCSCs
isolated from gestational diabetes mellitus (GDM) and
healthy pregnant women (N). GDM-UCSCs displayed
decreased cell growth and significantly lower osteogenic
and adipogenic differentiation potential then N-UCSCs.
Furthermore, GDM-UCSCs exhibited earlier cellular
senescence, low mitochondrial activity and reduced
expression of the mitochondrial regulatory genes. Also Liu
et al. [28] reported that MSCs isolated from bone marrow
gestational diabetes mellitus patients exhibited lower
growth than those isolated from a control group.
Relatively little is known about the biochemical mech-
anisms of toxicity of HCP at the cellular and molecular
level. According to the literature, HCP is a potent hemo-
lytic agent inducing hemolysis by association witch the
cellular membrane of red blood cells (RBC). Moreover,
residues of HPC were detected in the cytoplasm of sur-
viving RBCs [29]. Amdur et al. [30] showed that HCP
binds tightly to cell membrane resulting in the loss of ion
gradients. The major effect of HCP is the modification of
the permeability of cellular membrane, and in conse-
quence, the disruption of the efflux of monovalent cations
such as K? and Na?. The ultimate result of this process is
osmotic swelling and subsequent hemolysis of RBCs.
Osmoregulation of the erythrocytes is based on the balance
between the active and passive transport of K? and Na?.
Hemolysis may be the effect of the disruption of this bal-
ance [31]. The defective ion transport can lead to: direct
inhibition of (K?–Na?)-activated and Mg2?-dependent
ATPase and decreased efficiency of metabolic reactions.
These in turn lead to inhibition of oxidation and changes in
permeability of the cellular membrane [29]. Toxic mech-
anism of HCP associated with modifications of cell mem-
brane permeability and mitochondrial function partially
explains the results in our present study.
The HCP also influences the cellular energetic pro-
cesses. It has been shown that HCP in micromolar con-
centration upregulated respiration of rat liver and calf
brain’s mitochondria [32]. In higher concentrations, the
HCP acted as a potent uncoupler of oxidative phosphory-
lation in mitochondria and inhibited mitochondrial respi-
ration. The chemical structure of HCP is similar to that of
pentachlorothiophenol and halogenated phenols, which are
known as uncoupling agents of mitochondrial oxidative
phosphorylation [32]. We observed that 10-4 M HCP
caused both necrosis and apoptosis of MSCs while the
lower concentration (10-5 M) of HCP induced apoptosis. It
is well known that disruption of mitochondrial functions is
a major factor inducing apoptosis [33]. One of the mech-
anism by which HCP may affect cell apoptosis is its impact
on Wnt/b-catenin classic pathway [34]. Park et al. [35]
reported that HCP addition to colon cancer cell line
inhibited Wnt/-catenin signaling via degradation of the
intracellular b-catenin which was independent of GSK-3
and b-TrCP activation. Moreover HCP treatment inhibited
proliferation of colon cancer cells. Wnt/b-catenin signaling
pathway regulates function of T cells transcription factor
(TCF) and affects cellular processes such as embryogene-
sis, survival, differentiation and proliferation in cells [36].
This may also partly explain our results: attenuated pro-
liferation and differentiation after HCP addition.
We also showed that not only a constant presence of
10-4 M HCP in the differentiating medium inhibited MSCs
osteogenesis but that also preincubation (for 4–5 days
only) of MSCs with the 10-4 M HCP inhibited osteogen-
esis. This suggests that HCP causes permanent changes in
metabolism or genetics of MSCs. Because HCP is perma-
nently present in environment and accumulates in human
body its harmful effects on MSCs have to be taken into
consideration before medical application.
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